Shares of Corbus Pharmaceuticals Holdings Inc. /zigman2/quotes/201549545/lastsale CRBP +9.69% took a -10% dive 10.28% to $0.42 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.73% rising 0.50% to 14,417.55 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.43% rising 0.63% to 35,629.33. The stock's fall snapped a three-day winning streak. Corbus Pharmaceuticals Holdings Inc. closed $3.58 below its 52-week high ($4.00), which the company reached on February 11th.
The stock underperformed when compared to some of its competitors Wednesday, as Fate Therapeutics Inc. /zigman2/quotes/209623007/composite FATE -4.50% fell 3.70% to $39.59, Vanda Pharmaceuticals Inc. /zigman2/quotes/200957783/composite VNDA -2.47% fell 3.62% to $14.66, and Viking Therapeutics Inc. /zigman2/quotes/204618964/composite VKTX +8.79% fell 6.79% to $3.57. Trading volume (896,100) remained 92,567 below its 50-day average volume of 988,667.